Pre-treatment with bacterial lipase improves the reliability of electroimmunoassay for quantifying B apoprotein in plasma lipoproteins.
No takes yet. Share an insight, caveat, or question.
May enhance apoB assay reliability in labs; leaves open effects on clinical risk assessment.
Reardon et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: